跳至主要内容
临床试验/JPRN-C000000005
JPRN-C000000005已完成2 期

Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2) - Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2)

Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 56 人开始时间: 2005年6月7日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
56

研究概览

简要总结

See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • -synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ -pregnant or nursing -severe mental disorders -systemic and continuous use of steroidal drugs -active infections -uncontrolled hypertension -diabetes mellitus, uncontrolled or controlled with insulin -history of cardiac failure, unstable angina, myocardial infarction within 6 months prior to the registration -liver cirrhosis or bleeding tendency contraindicating debulking surgery -intestinal occlusion necessary for surgical treatment -hypersensitivity to alcohol

研究者

发起方
Japan Clinical Oncology Group(JCOG)

相似试验